These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 958001)

  • 1. Improvement of growth hormone response to stimulation in primary aldosteronism with correction of potassium deficiency.
    Podolsky S; Melby JC
    Metabolism; 1976 Sep; 25(9):1027-32. PubMed ID: 958001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth-hormone and insulin response to stimulation.
    Podolsky S; Zimmerman HJ; Burrows BA; Cardarelli JA; Pattavina CG
    N Engl J Med; 1973 Mar; 288(13):644-8. PubMed ID: 4687256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exchangeable electrolytes, glycoregulation and growth hormone in one case of Bartter's syndrome (author's transl)].
    Lefebvre J; Racadot A; Dequiedt P; Linquette M
    Ann Endocrinol (Paris); 1977; 38(6):385-6. PubMed ID: 612271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
    Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
    Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
    Leopold NA; Podolsky S
    J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
    Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
    Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
    Conn JW; Hinerman DL
    Metabolism; 1977 Dec; 26(12):1293-307. PubMed ID: 927164
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
    Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hypokalemia on glucose metabolism in primary hyperaldosteronism].
    Zhang J; Zeng ZP; Zhou YR; Tong AL; Lu L; Song AL; Yan ZL; Chen S; Liang W; Li YX; Qin SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):745-9. PubMed ID: 17260459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
    Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
    Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normotensive primary aldosteronism: report of a case.
    Kono T; Ikeda F; Oseko F; Imura H; Tanimura H
    J Clin Endocrinol Metab; 1981 May; 52(5):1009-13. PubMed ID: 6262353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man.
    Dluhy RG; Axelrod L; Williams GH
    J Appl Physiol; 1972 Jul; 33(1):22-6. PubMed ID: 4556620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiopathological and functional semeiologic considerations in a case of primary normoaldosteronemic hyperaldosteronism].
    Bruschi G; Banchini E; Mutti A; Biggi A; Coruzzi P; Civardi E; Martinelli M; Novarini A
    Ateneo Parmense Acta Biomed; 1977; 48(2):157-65. PubMed ID: 883997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease.
    Podolsky S; Leopold NA
    Gerontology; 1977; 23(1):55-63. PubMed ID: 136379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I.
    Flyvbjerg A; Dørup I; Everts ME; Orskov H
    Metabolism; 1991 Aug; 40(8):769-75. PubMed ID: 1861625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
    Beretta-Piccoli C; Weidmann P; Brown JJ; Fraser R; Lever AF; Marone C; Robertson JI
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):66-71. PubMed ID: 6751010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
    Biglieri EG; Schambelan M
    J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.